Coeptis Therapeutics Inc. (COEP)
NASDAQ: COEP
· Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT
Coeptis Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.42M | -3.01M | -1.83M | -3.04M | -3M | -3.76M | -6.26M | -3.11M | -7.87M | -2.94M | -5.65M | -9.8M | -19.18M | -2.84M | -5.95M | -2.71M | -1.95M |
Depreciation & Amortization | 305.3K | 259.98K | 278.23K | 250.21K | 250.21K | 250.31K | 250.31K | 250.31K | 250.31K | 250.35K | 250.35K | 250.35K | 250.35K | 446.2K | 366.00 | 367.00 | 481.00 |
Stock-Based Compensation | 597.73K | 299.63K | 805.35K | 611.57K | 96.89K | 128.51K | 113.3K | 113.3K | 122.39K | n/a | n/a | n/a | n/a | n/a | 1.9M | n/a | n/a |
Other Working Capital | n/a | -137.05K | 8.08K | 138.23K | 140.67K | 8.63K | 94.65K | 56.26K | 43.55K | -669.08K | 54.32K | -208 | 66.66K | -329 | -1M | -862.68K | 336.25K |
Other Non-Cash Items | n/a | 1.06M | -300K | 784.85K | 1.32M | 506.05K | 4.85M | 351K | 5.62M | 2.74M | 4.26M | 175.7K | 17.79M | 3.24M | 607.5K | 2.68M | 770K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 807.8K | -1.09M | 286.5K | n/a | n/a | n/a | n/a | n/a | n/a | 2.3M | n/a | n/a |
Change in Working Capital | n/a | 80.97K | -138.82K | -29.02K | 86.87K | 907.35K | 181.43K | 209.04K | 195.05K | -897.93K | 105.65K | 64.58K | 177.37K | -1.06M | -2.51M | 62.33K | 524.33K |
Operating Cash Flow | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M | -1.68M | -847.35K | -1.03M | -1.03M | -961.73K | -208.88K | -3.65M | 24.86K | -655.27K |
Capital Expenditures | n/a | -1 | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.05M | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 333.33K | -133.33K | -200K | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43.03M | n/a | 43.03M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 100K | 42.59M | n/a | -100K | n/a | 350K | -350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 100K | 42.59M | n/a | -100K | n/a | 350K | -350K | n/a | -42.69M | -133.33K | 42.83M | n/a | 3.05M | -4.05M | n/a | n/a |
Debt Repayment | n/a | -1.26M | n/a | 200K | 1.06M | -200K | -725K | 350K | n/a | -2.59M | -50K | 173.82K | -250K | -5.32M | 4.75M | -931.9K | -122.41K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.1M | 2.49M | -50K | 50K | n/a | 200K | n/a | n/a | n/a | -141.44K | 4.76M | 43.92M | 110K | -1.13M | 1.29M | 82.5K | -298.06K |
Financial Cash Flow | 6.1M | 731.97K | 1.47M | 1.94M | 1.56M | 1.75M | -224.93K | 3.39M | n/a | -2.73M | 6.03M | 1.07M | 1.13M | -3.48M | 8.6M | 601.72K | 2.49M |
Net Cash Flow | 3.74M | -604.57K | -417.62K | 525.83K | -439.89K | 57.62K | -1.83M | 1.14M | -1.68M | -3.58M | 4.99M | 34.47K | 164.27K | -630.3K | 898.56K | -123.42K | 1.83M |
Free Cash Flow | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M | -1.68M | -847.35K | -1.03M | -1.03M | -961.73K | -208.88K | -7.7M | 24.86K | -655.27K |